Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 6.

Wiedl, T; Collaud, S; Hillinger, S; Arni, S; Burgess, C; Kroll, W; Schraml, P; Soltermann, A; Moch, H; Weder, W (2012). KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics & Proteomics, 9(1):51-54.

Collaud, S; Lardinois, D; Tischler, V; Steinert, H C; Stahel, R; Weder, W (2012). Significance of a new fluorodeoxyglucose-positive lesion on restaging positron emission tomography/computed tomography after induction therapy for non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery, 41(3):612-616.

Wiedl, T; Arni, S; Roschitzki, B; Grossmann, J; Collaud, S; Soltermann, A; Hillinger, S; Aebersold, R; Weder, W (2011). Activity-based proteomics: identification of ABHD11 and ESD activities as potential biomarkers for human lung adenocarcinoma. Journal of Proteomics, 74(10):1884-1894.

Weder, W; Collaud, S; Eberhardt, W E E; Hillinger, S; Welter, S; Stahel, R; Stamatis, G (2010). Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. Journal of Thoracic and Cardiovascular Surgery, 139(6):1424-1430.

Collaud, S; Wiedl, T; Cattaneo, E; Soltermann, A; Hillinger, S; Weder, W; Arni, S (2010). Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. Journal of Biomolecular Techniques, 21(1):25-28.

Collaud, S; Remmen, F; Weder, W (2009). Transphrenic budding of the liver. Annals of Thoracic Surgery, 88(4):1364.

This list was generated on Sat Nov 25 03:37:07 2017 CET.